Anti-Human CD2 Recombinant Antibody
-
产品编号
YR1030
-
别名
科研级 Siplizumab ( 西利珠单抗 ), Anti-CD2 Recombinant Antibody, Research Grade Siplizumab
-
规格
- 1mg
- 5mg
产品中心
Alias | 科研级 Siplizumab ( 西利珠单抗 ), Anti-CD2 Recombinant Antibody, Research Grade Siplizumab |
Catalog Number | YR1030 |
Molecular Name | Siplizumab |
Host | Rat |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Kappa |
Formulation | PBS, pH7.5 |
Background | Siplizumab (MEDI-507) is a novel monoclonal antibody with a human IgG1, kappa directed to CD2. The agent has shown potent immunomodulatory effects, selectively suppressing the function of T and NK cells, and is currently being tested as a possible treatment for psoriasis and in the prevention of graft-versus-host disease. |
CAS Number | 288392-69-8 |
Application | ELISA, IP, FCM, FuncS, Neut, IF, ICC |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | CD2[Homo sapiens] |
销售微信
官方公众号
可以介绍下你们的产品么
你们是怎么收费的呢
现在有优惠活动吗
感谢您的关注,当前客服人员不在线,请填写一下您的信息,我们会尽快和您联系。